Decreased mitochondrial complex I activity in blood lymphocytes of patients with idiopathic pulmonary fibrosis
E. Zifa (Larissa, Greece), I. Dimeas (Larissa, Greece), A. Mouikis (Larissa, Greece), A. Pozantzi (Larissa, Greece), K. Rossi (Larissa, Greece), A. Psarra (Larissa, Greece), S. Sinis (Larissa, Greece), F. Bardaka (Larissa, Greece), F. Malli (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), Z. Daniil (Larissa, Greece)
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Zifa (Larissa, Greece), I. Dimeas (Larissa, Greece), A. Mouikis (Larissa, Greece), A. Pozantzi (Larissa, Greece), K. Rossi (Larissa, Greece), A. Psarra (Larissa, Greece), S. Sinis (Larissa, Greece), F. Bardaka (Larissa, Greece), F. Malli (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), Z. Daniil (Larissa, Greece). Decreased mitochondrial complex I activity in blood lymphocytes of patients with idiopathic pulmonary fibrosis. 3379
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006
The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012
Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002
Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Induced sputum glutathione levels are decreased in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011
Increased priming of blood neutrophils in children with clinically stable cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002
Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010
Expression of apoptotic markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 376s Year: 2003
Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010
Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
The effect of inferon on oxygen-dependent metabolism of blood cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 1171-1183 Year: 2016
Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011
Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016
Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis Source: Eur Respir J, 56 (3) 1902058; 10.1183/13993003.02058-2019 Year: 2020
Standard therapy increases the sensitivity of peripheral blood lymphocytes to glucocorticoids in cystic fibrosis but not in severe asthma Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011